{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T20:48:05Z","timestamp":1793134085786,"version":"4.5.0"},"reference-count":197,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jaci.2025.10.025","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:15:15Z","timestamp":1762503315000},"page":"1-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Understanding IgE-mediated autoimmunity and autoallergy"],"prefix":"10.1016","volume":"157","author":[{"given":"Sherezade","family":"Mo\u00f1ino-Romero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge","family":"Kortekaas Krohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Kui","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Altrichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrine","family":"Baumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hafsa","family":"Belasri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique","family":"Butze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shauni","family":"de Vriese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Frischbutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Gutermuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emek","family":"Kocat\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Maria","family":"Matricardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melba","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent L.","family":"Reber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per Stahl","family":"Skov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Steinert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Charles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5380-8132","authenticated-orcid":false,"given":"Pavel","family":"Kolkhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2025.10.025_bib1","series-title":"Multiple chronic conditions in the United States","author":"Bauman","year":"2017"},{"key":"10.1016\/j.jaci.2025.10.025_bib2","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib3","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.10.025_bib4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12931-023-02475-6","article-title":"Global, regional, and national burden of asthma and its attributable risk factors from 1990 to 2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"24","author":"Wang","year":"2023","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2025.10.025_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaci.2018.11.006","article-title":"The atopic march and atopic multimorbidity: many trajectories, many pathways","volume":"143","author":"Paller","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib6","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1016\/j.jaci.2024.11.036","article-title":"Mortality in adult patients with chronic spontaneous urticaria: a real-world cohort study","volume":"155","author":"Kolkhir","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/bjd\/ljad339","article-title":"Global epidemiology of atopic dermatitis: a comprehensive systematic analysis and modelling study","volume":"190","author":"Tian","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib195","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/S0140-6736(63)90171-5","article-title":"Infantile eczema. Evidence of autoimmunity to human skin","volume":"2","author":"Hashem","year":"1963","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.10.025_bib196","first-page":"581","article-title":"Antinuclear antibodies of the IgE and IgD classes in sera of patients with systemic lupus erythematosus (SLE)","volume":"21","author":"Jackson","year":"1973","journal-title":"Clin Res"},{"key":"10.1016\/j.jaci.2025.10.025_bib197","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2008.11.035","article-title":"Pathogenicity of IgE in autoimmunity: successful treatment of bullous pemphigoid with omalizumab","volume":"123","author":"Fairley","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib8","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1111\/all.15843","article-title":"Autoreactive IgE: pathogenic role and therapeutic target in autoimmune diseases","volume":"78","author":"Charles","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib9","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1038\/s41591-024-02819-9","article-title":"The European Network for IgE-Mediated Autoimmunity and Autoallergy (ENIGMA) initiative","volume":"30","author":"Kolkhir","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.10.025_bib11","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1111\/jdv.18345","article-title":"European guideline (EuroGuiDerm) on atopic eczema: part I\u2014systemic therapy","volume":"36","author":"Wollenberg","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2025.10.025_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41533-023-00330-1","article-title":"Key recommendations for primary care from the 2022 Global Initiative for Asthma (GINA) update","volume":"33","author":"Levy","year":"2023","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib13","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaci.2025.03.003","article-title":"Identifying allergic and nonallergic type 2 asthma endotypes: moving beyond blood eosinophil counts and fractional exhaled nitric oxide","volume":"156","author":"Adcock","year":"2025","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib14","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib15","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/j.jaci.2022.04.010","article-title":"Autoimmune chronic spontaneous urticaria","volume":"149","author":"Kolkhir","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2025.10.025_bib17","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1111\/jdv.18220","article-title":"Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)","volume":"36","author":"Borradori","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaci.2025.10.025_bib18","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/all.14690","article-title":"EAACI biologicals guidelines\u2014dupilumab for children and adults with moderate-to-severe atopic dermatitis","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib19","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/all.14425","article-title":"EAACI biologicals guidelines\u2014recommendations for severe asthma","volume":"76","author":"Agache","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib20","article-title":"Effectiveness of transitioning from omalizumab to dupilumab in chronic spontaneous urticaria patients with inadequate response to omalizumab","volume":"18","author":"Hayama","year":"2025","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2025.10.025_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2025.102591","article-title":"Immunotherapy for pemphigus and bullous pemphigoid","volume":"95","author":"Xu","year":"2025","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib22","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2025.10.025_bib23","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1136\/ard-2023-225319","article-title":"Management of systemic lupus erythematosus: a systematic literature review informing the 2023 update of the EULAR recommendations","volume":"83","author":"Kostopoulou","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2025.10.025_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2020.01.089","article-title":"Dupilumab as a novel therapy for bullous pemphigoid: a multicenter case series","volume":"83","author":"Abdat","year":"2020","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib25","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/ACI.0000000000001095","article-title":"Biologic and small molecule therapies in chronic spontaneous urticaria: an update","volume":"25","author":"Wedi","year":"2025","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib26","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.jaci.2016.04.004","article-title":"The discovery of IgE","volume":"137","author":"Johansson","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib27","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1146\/annurev.immunol.17.1.931","article-title":"The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology","volume":"17","author":"Kinet","year":"1999","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib28","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1111\/all.14724","article-title":"The role of CD23 in the regulation of allergic responses","volume":"76","author":"Engeroff","year":"2021","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib29","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib30","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41581-023-00720-1","article-title":"Pathogenesis of autoimmune disease","volume":"19","author":"Pisetsky","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.jaci.2025.10.025_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.immunol.26.021607.090248","article-title":"Mechanism and regulation of class switch recombination","volume":"26","author":"Stavnezer","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib32","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(01)49802-3","article-title":"Lumleian lectures on some points in the \u00e6tiology of skin diseases","volume":"198","author":"Whitfield","year":"1921","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.10.025_bib33","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.jaci.2009.05.015","article-title":"Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema","volume":"124","author":"Zeller","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib34","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2017.10.035","article-title":"IL-24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria","volume":"142","author":"Schmetzer","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib35","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1111\/all.13832","article-title":"Increased expression of IL-24 in chronic spontaneous urticaria","volume":"74","author":"de Montjoye","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib36","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S0952-7915(00)00153-9","article-title":"Regulation of the IgE isotype switch: new insights on cytokine signals and the functions of epsilon germline transcripts","volume":"12","author":"Oettgen","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47769-2","article-title":"Human thioredoxin, a damage-associated molecular pattern and Malassezia-crossreactive autoallergen, modulates immune responses via the C-type lectin receptors Dectin-1 and Dectin-2","volume":"9","author":"Roesner","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jaci.2025.10.025_bib38","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/bip.20458","article-title":"Phosphorylated and nonphosphorylated epitopes of the La\/SSB autoantigen: comparison of their antigenic and conformational characteristics","volume":"84","author":"Coudevylle","year":"2006","journal-title":"Biopolymers"},{"key":"10.1016\/j.jaci.2025.10.025_bib39","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1038\/jid.2008.132","article-title":"Bullous pemphigoid autoantibodies preferentially recognize phosphoepitopes in collagen XVII","volume":"128","author":"Zimina","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib40","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1067\/mai.2000.104783","article-title":"Autoallergy: a pathogenetic factor in atopic dermatitis?","volume":"105","author":"Valenta","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib41","doi-asserted-by":"crossref","DOI":"10.1111\/exd.15058","article-title":"Presence of immunoglobulin E\u2013expressing antibody-secreting cells in the dermis close to bullous pemphigoid lesions","volume":"33","author":"Budair","year":"2024","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib42","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/ni.3326","article-title":"Self-reactive IgE exacerbates interferon responses associated with autoimmunity","volume":"17","author":"Henault","year":"2016","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib43","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nm.2159","article-title":"Basophils and the T helper 2 environment can promote the development of lupus nephritis","volume":"16","author":"Charles","year":"2010","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib44","doi-asserted-by":"crossref","first-page":"3480","DOI":"10.1093\/rheumatology\/kead082","article-title":"Anti-dsDNA IgE induces IL-4 production from basophils, potentially involved in B-cell differentiation in systemic lupus erythematosus","volume":"62","author":"Fujimoto","year":"2023","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaci.2025.10.025_bib45","doi-asserted-by":"crossref","first-page":"3389","DOI":"10.1038\/s41467-024-47691-w","article-title":"PD-L1\u2013 and IL-4\u2013expressing basophils promote pathogenic accumulation of T follicular helper cells in lupus","volume":"15","author":"Tchen","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.10.025_bib46","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13601-020-00338-7","article-title":"IgE autoantibodies and autoreactive T cells and their role in children and adults with atopic dermatitis","volume":"10","author":"Badloe","year":"2020","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib47","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1439-0507.2008.01644.x","article-title":"Cross-reactivity among fungal allergens: a clinically relevant phenomenon?","volume":"52","author":"Crameri","year":"2009","journal-title":"Mycoses"},{"key":"10.1016\/j.jaci.2025.10.025_bib48","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nri724","article-title":"Epitope spreading in immune-mediated diseases: implications for immunotherapy","volume":"2","author":"Vanderlugt","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib49","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jaut.2018.10.012","article-title":"Molecular mimicry and autoimmunity","volume":"95","author":"Rojas","year":"2018","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2025.10.025_bib50","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaip.2020.09.030","article-title":"Clinical relevance of cross-reactivity in food allergy","volume":"9","author":"Cox","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.025_bib51","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1111\/j.1398-9995.2008.01777.x","article-title":"Auto- and cross-reactivity to thioredoxin allergens in allergic bronchopulmonary aspergillosis","volume":"63","author":"Glaser","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib52","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jaci.2011.02.043","article-title":"Malassezia sympodialis thioredoxin-specific T cells are highly cross-reactive to human thioredoxin in atopic dermatitis","volume":"128","author":"Balaji","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib53","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4049\/jimmunol.178.1.389","article-title":"Cross-reactivity and 1.4-A crystal structure of Malassezia sympodialis thioredoxin (Mala s 13), a member of a new pan-allergen family","volume":"178","author":"Limacher","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2005.11.040","article-title":"Wheat and maize thioredoxins: a novel cross-reactive cereal allergen family related to baker\u2019s asthma","volume":"117","author":"Weichel","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib55","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/1521-4141(200201)32:1<10::AID-IMMU10>3.0.CO;2-I","article-title":"Cyclophilins, a new family of cross-reactive allergens","volume":"32","author":"Fluckiger","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.184.1.265","article-title":"Humoral and cell-mediated autoimmunity in allergy to Aspergillus fumigatus","volume":"184","author":"Crameri","year":"1996","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib57","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2005.01.065","article-title":"IgE-mediated and T cell\u2013mediated autoimmunity against manganese superoxide dismutase in atopic dermatitis","volume":"115","author":"Schmid-Grendelmeier","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib58","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1126\/science.1857985","article-title":"Identification of profilin as a novel pollen allergen; IgE autoreactivity in sensitized individuals","volume":"253","author":"Valenta","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.jaci.2025.10.025_bib59","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1084\/jem.189.9.1507","article-title":"Humoral and cell-mediated autoimmune reactions to human acidic ribosomal P2 protein in individuals sensitized to Aspergillus fumigatus P2 protein","volume":"189","author":"Mayer","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib60","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/intimm\/1.2.191","article-title":"Stress proteins may provide a link between the immune response to infection and autoimmunity","volume":"1","author":"Lamb","year":"1989","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib61","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/bjd.13695","article-title":"Frequency of autoallergy to manganese superoxide dismutase in patients with atopic dermatitis: experience of three Italian dermatology centres","volume":"173","author":"Guarneri","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib62","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1111\/j.1432-1033.2004.04098.x","article-title":"Cloning, expression and characterization of two new IgE-binding proteins from the yeast Malassezia sympodialis with sequence similarities to heat shock proteins and manganese superoxide dismutase","volume":"271","author":"Andersson","year":"2004","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jaci.2025.10.025_bib63","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000063862","article-title":"Immunological and structural analysis of IgE-mediated cross-reactivity between manganese superoxide dismutases","volume":"128","author":"Fluckiger","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib64","first-page":"213","article-title":"Cloning, production, characterization and IgE cross-reactivity of different manganese superoxide dismutases in individuals sensitized to Aspergillus fumigatus","volume":"113","author":"Mayer","year":"1997","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib65","doi-asserted-by":"crossref","first-page":"6107","DOI":"10.3390\/ijms20246107","article-title":"Identification of B cell epitopes of Blo t 13 allergen and cross-reactivity with human adipocytes and heart fatty acid binding proteins","volume":"20","author":"Munera","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jaci.2025.10.025_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.imlet.2020.02.003","article-title":"Identification of antigenic epitopes of thyroperoxidase, thyroglobulin and interleukin-24. Exploration of cross-reactivity with environmental allergens and possible role in urticaria and hypothyroidism","volume":"220","author":"Sanchez","year":"2020","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2025.10.025_bib67","doi-asserted-by":"crossref","first-page":"746","DOI":"10.4168\/aair.2021.13.5.746","article-title":"Presence of IgE autoantibodies against eosinophil peroxidase and eosinophil cationic protein in severe chronic spontaneous urticaria and atopic dermatitis","volume":"13","author":"S\u00e1nchez","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2025.10.025_bib68","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1016\/j.jaci.2016.01.057","article-title":"IgG and IgG4 to 91 allergenic molecules in early childhood by route of exposure and current and future IgE sensitization: results from the Multicentre Allergy Study birth cohort","volume":"138","author":"Schwarz","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib69","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jaci.2014.09.048","article-title":"\u201cDefault\u201d versus \u201cpre-atopic\u201d IgG responses to foodborne and airborne pathogenesis-related group 10 protein molecules in birch-sensitized and nonatopic children","volume":"135","author":"Hofmaier","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib70","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1067\/mai.2000.107039","article-title":"Autoantibodies to DFS 70 kd\/transcription coactivator p75 in atopic dermatitis and other conditions","volume":"105","author":"Ochs","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib71","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.clim.2009.11.006","article-title":"Clinical activity of pemphigus vulgaris relates to IgE autoantibodies against desmoglein 3","volume":"134","author":"Nagel","year":"2010","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib72","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jim.2009.04.013","article-title":"A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid","volume":"346","author":"Messingham","year":"2009","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jaci.2025.10.025_bib73","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.0022-202X.2005.23853.x","article-title":"Mapping the binding sites of anti-BP180 immunoglobulin E autoantibodies in bullous pemphigoid","volume":"125","author":"Fairley","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib74","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/bjd.15924","article-title":"IgE autoreactivity in bullous pemphigoid: eosinophils and mast cells as major targets of pathogenic immune reactants","volume":"177","author":"Freire","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib75","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jdermsci.2024.03.009","article-title":"Anti-BP230 IgE autoantibodies in bullous pemphigoid intraindividually correlate with disease activity","volume":"114","author":"Emtenani","year":"2024","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaci.2025.10.025_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1111\/cei.13428","article-title":"Co-occurrence of IgE and IgG autoantibodies in patients with chronic spontaneous urticaria","volume":"200","author":"Asero","year":"2020","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib77","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1016\/j.jaip.2023.02.006","article-title":"Most patients with autoimmune chronic spontaneous urticaria also have autoallergic urticaria, but not vice versa","volume":"11","author":"Xiang","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.jaci.2025.10.025_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014794","article-title":"IgE mediated autoallergy against thyroid peroxidase\u2014a novel pathomechanism of chronic spontaneous urticaria?","volume":"6","author":"Altrichter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.10.025_bib79","doi-asserted-by":"crossref","first-page":"131","DOI":"10.4168\/aair.2022.14.1.131","article-title":"IgE and IgG anti-thyroid autoantibodies in Chinese patients with chronic spontaneous urticaria and a literature review","volume":"14","author":"Zhang","year":"2022","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2025.10.025_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090424","article-title":"Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis","volume":"9","author":"Dema","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jaci.2025.10.025_bib81","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0673","article-title":"CD23+IgG1+ memory B cells are poised to switch to pathogenic IgE production in food allergy","volume":"16","author":"Ota","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib82","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adi0944","article-title":"Type 2\u2013polarized memory B cells hold allergen-specific IgE memory","volume":"16","author":"Koenig","year":"2024","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib83","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1002\/1521-4141(200202)32:2<576::AID-IMMU576>3.0.CO;2-U","article-title":"Evolution of IgM, IgE and IgG1-4 antibody responses in early childhood monitored with recombinant allergen components: implications for class switch mechanisms","volume":"32","author":"Niederberger","year":"2002","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib84","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jaci.2004.02.046","article-title":"How do we avoid developing allergy: modifications of the TH2 response from a B-cell perspective","volume":"113","author":"Aalberse","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib85","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3389\/fimmu.2013.00235","article-title":"A temporal model of human IgE and IgG antibody function","volume":"4","author":"Collins","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib86","series-title":"Allergy, immunity and tolerance in early childhood","first-page":"19","article-title":"Immunological aspects of the atopic march","author":"Aalberse","year":"2016"},{"key":"10.1016\/j.jaci.2025.10.025_bib87","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1096\/fasebj.12.14.1559","article-title":"Isolation of cDNA clones coding for IgE autoantigens with serum IgE from atopic dermatitis patients","volume":"12","author":"Natter","year":"1998","journal-title":"FASEB J"},{"key":"10.1016\/j.jaci.2025.10.025_bib88","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.jaci.2005.06.025","article-title":"The cradle of IgE autoreactivity in atopic eczema lies in early infancy","volume":"116","author":"Mothes","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib89","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1111\/all.15822","article-title":"Immunoglobulin E autoantibodies in atopic dermatitis associate with type-2 comorbidities and the atopic march","volume":"78","author":"Kortekaas Krohn","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib90","article-title":"Significance of anti-TPO as an early predictive marker in thyroid disease","volume":"2019","author":"Siriwardhane","year":"2019","journal-title":"Autoimmune Dis"},{"key":"10.1016\/j.jaci.2025.10.025_bib91","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib92","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jaci.2025.10.025_bib93","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-021-00538-7","article-title":"Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions?","volume":"21","author":"Akdis","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib94","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1007\/s00431-020-03616-5","article-title":"Genetic predisposition and environmental factors associated with the development of atopic dermatitis in infancy: a prospective birth cohort study","volume":"179","author":"Gallay","year":"2020","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaci.2025.10.025_bib95","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2016.02.045","article-title":"Resolving the etiology of atopic disorders by using genetic analysis of racial ancestry","volume":"138","author":"Gupta","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib96","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4202145","article-title":"Clinical characterization of patients with chronic spontaneous urticaria according to anti-TPO IgE levels","volume":"2019","author":"Sanchez","year":"2019","journal-title":"J Immunol Res"},{"key":"10.1016\/j.jaci.2025.10.025_bib97","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1084\/jem.20140066","article-title":"Immunoglobulin E plays an immunoregulatory role in lupus","volume":"211","author":"Dema","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib98","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/j.immuni.2018.10.012","article-title":"The transcription factor Ets1 suppresses T follicular helper type 2 cell differentiation to halt the onset of systemic lupus erythematosus","volume":"49","author":"Kim","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.10.025_bib99","doi-asserted-by":"crossref","first-page":"348","DOI":"10.3389\/fimmu.2017.00348","article-title":"Basophil activation\u2013dependent autoantibody and interleukin-17 production exacerbate systemic lupus erythematosus","volume":"8","author":"Pan","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib100","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaut.2010.06.007","article-title":"The use of mouse models to better understand mechanisms of autoimmunity and tolerance","volume":"35","author":"Miyagawa","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2025.10.025_bib101","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/s41590-019-0493-z","article-title":"House dust mites activate nociceptor\u2013mast cell clusters to drive type 2 skin inflammation","volume":"20","author":"Serhan","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib102","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/jid.2013.250","article-title":"Mast cells are required for full expression of allergen\/SEB-induced skin inflammation","volume":"133","author":"Ando","year":"2013","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib103","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jaci.2004.05.029","article-title":"Induction of autoallergy with an environmental allergen mimicking a self protein in a murine model of experimental allergic asthma","volume":"114","author":"B\u00fcnder","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib104","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1196\/annals.1381.044","article-title":"Autosensitization as a pathomechanism in asthma","volume":"1107","author":"Garn","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.jaci.2025.10.025_bib105","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jaut.2008.08.009","article-title":"Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model","volume":"31","author":"Liu","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.jaci.2025.10.025_bib106","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.jid.2017.11.031","article-title":"Eosinophils mediate tissue injury in the autoimmune skin disease bullous pemphigoid","volume":"138","author":"Lin","year":"2018","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib107","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4049\/jimmunol.2300080","article-title":"The eotaxin-1\/CCR3 axis and matrix metalloproteinase-9 are critical in anti-NC16A IgE-induced bullous pemphigoid","volume":"211","author":"Jordan","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib108","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1172\/JCI11494","article-title":"Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid","volume":"108","author":"Chen","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.10.025_bib109","doi-asserted-by":"crossref","first-page":"15003","DOI":"10.1074\/jbc.M111.221036","article-title":"The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid","volume":"286","author":"Heimbach","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.10.025_bib110","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/sj.jid.5700681","article-title":"IgE basement membrane zone antibodies induce eosinophil infiltration and histological blisters in engrafted human skin on SCID mice","volume":"127","author":"Zone","year":"2007","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib111","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/08916934.2017.1280670","article-title":"Pathogenic mechanisms of IgE-mediated inflammation in self-destructive autoimmune responses","volume":"50","author":"Ettinger","year":"2017","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jaci.2025.10.025_bib112","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000288293","article-title":"Autoimmune response of IgE antibodies to cellular self-antigens in systemic lupus erythematosus","volume":"152","author":"Atta","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib113","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2023.2273981","article-title":"Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation","volume":"45","author":"Chen","year":"2023","journal-title":"Ren Fail"},{"key":"10.1016\/j.jaci.2025.10.025_bib114","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jaci.2022.05.023","article-title":"Comprehensive overview of autoantibody isotype and subclass distribution","volume":"150","author":"Volkov","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib115","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/j.jaci.2020.12.622","article-title":"Basophils and IgE contribute to mixed connective tissue disease development","volume":"147","author":"Lamri","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib116","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/s41590-020-0677-6","article-title":"Autoimmunity and organ damage in systemic lupus erythematosus","volume":"21","author":"Tsokos","year":"2020","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib117","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","article-title":"The immune cell landscape in kidneys of patients with lupus nephritis","volume":"20","author":"Arazi","year":"2019","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.900532","article-title":"CT-M8 mice: a new mouse model demonstrates that basophils have a nonredundant role in lupus-like disease development","volume":"13","author":"Tchen","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib119","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4049\/jimmunol.130.1.327","article-title":"The interaction of human and rodent IgE with the human basophil IgE receptor","volume":"130","author":"Conrad","year":"1983","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib120","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jaci.2016.04.034","article-title":"A humanized mouse model of anaphylactic peanut allergy","volume":"139","author":"Burton","year":"2017","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib121","doi-asserted-by":"crossref","first-page":"22079","DOI":"10.1016\/S0021-9258(18)45670-0","article-title":"The alpha subunit of the human IgE receptor (FcERI) is sufficient for high affinity IgE binding","volume":"265","author":"Hakimi","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jaci.2025.10.025_bib122","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.4049\/jimmunol.157.4.1645","article-title":"Anaphylaxis mediated through a humanized high affinity IgE receptor","volume":"157","author":"Dombrowicz","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib123","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S1074-7613(00)80556-7","article-title":"Allergy-associated FcRbeta is a molecular amplifier of IgE- and IgG-mediated in vivo responses","volume":"8","author":"Dombrowicz","year":"1998","journal-title":"Immunity"},{"key":"10.1016\/j.jaci.2025.10.025_bib124","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1172\/JCI36452","article-title":"FcgammaRIV is a mouse IgE receptor that resembles macrophage FcepsilonRI in humans and promotes IgE-induced lung inflammation","volume":"118","author":"Mancardi","year":"2008","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.10.025_bib125","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1172\/JCI129697","article-title":"The anti-IgE mAb omalizumab induces adverse reactions by engaging Fcgamma receptors","volume":"130","author":"Balbino","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaci.2025.10.025_bib126","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jaci.2012.10.018","article-title":"Blockade of peanut allergy with a novel Ara h 2\u2013Fcgamma fusion protein in mice","volume":"131","author":"Liu","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib127","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.4049\/jimmunol.2100497","article-title":"A novel method for total IgE purification from human serum","volume":"208","author":"Badloe","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib128","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.4049\/jimmunol.150.4.1365","article-title":"Fine specificity of the IgE interaction with the low and high affinity Fc receptor","volume":"150","author":"Nissim","year":"1993","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib129","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.jaci.2012.02.002","article-title":"Does \u201cautoreactivity\u201d play a role in atopic dermatitis?","volume":"129","author":"Tang","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nsmb.2795","article-title":"Human immunoglobulin E flexes between acutely bent and extended conformations","volume":"21","author":"Drinkwater","year":"2014","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.jaci.2025.10.025_bib131","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/intimm\/dxg036","article-title":"Evidence of allosteric conformational changes in the antibody constant region upon antigen binding","volume":"15","author":"Oda","year":"2003","journal-title":"Int Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib132","doi-asserted-by":"crossref","first-page":"271","DOI":"10.23822\/EurAnnACI.1764-1489.320","article-title":"Quantity increase and functional affinity\/avidity decrease of anti-FcepsilonRI and anti-IgE autoantibodies in chronic spontaneous urticaria","volume":"56","author":"Joerg","year":"2024","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib133","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/j.jaci.2017.11.021","article-title":"Isotype-specific agglutination-PCR (ISAP): a sensitive and multiplex method for measuring allergen-specific IgE","volume":"141","author":"Tsai","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib134","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/all.16403","article-title":"LuLIPLEX: a Fast, highly sensitive, and multiplexed method for the detection of IgE against major allergens","volume":"80","author":"Leveque","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib135","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1038\/jid.2008.80","article-title":"Serum IgE autoantibodies target keratinocytes in patients with atopic dermatitis","volume":"128","author":"Altrichter","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib136","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jaci.2018.12.1021","article-title":"Molecular diagnosis for allergen immunotherapy","volume":"143","author":"Matricardi","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib137","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1111\/all.16377","article-title":"A microarray-based IgE\u2013molecular mimicry index (IgE-MMI): a biomarker for disease severity, clinical phenotypes, and therapeutic response in atopic dermatitis?","volume":"79","author":"Scala","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib138","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4168\/aair.2019.11.1.29","article-title":"Causal relationship between anti-TPO IgE and chronic urticaria by in vitro and in vivo tests","volume":"11","author":"Sanchez","year":"2019","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaci.2025.10.025_bib139","doi-asserted-by":"crossref","first-page":"705","DOI":"10.3346\/jkms.2015.30.6.705","article-title":"Serum specific IgE to thyroid peroxidase activates basophils in aspirin intolerant urticaria","volume":"30","author":"Shin","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaci.2025.10.025_bib140","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100742","article-title":"Immunoglobulin E and G autoantibodies against eosinophil proteins in children and adults with asthma and healthy subjects","volume":"16","author":"Sanchez","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.jaci.2025.10.025_bib141","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.3389\/fimmu.2019.02331","article-title":"The Intersection of IgE Autoantibodies and eosinophilia in the pathogenesis of bullous pemphigoid","volume":"10","author":"Messingham","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib142","doi-asserted-by":"crossref","first-page":"553","DOI":"10.4049\/jimmunol.1001753","article-title":"FcR-independent effects of IgE and IgG autoantibodies in bullous pemphigoid","volume":"187","author":"Messingham","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib143","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41467-018-03129-8","article-title":"Prostaglandin D2 amplifies lupus disease through basophil accumulation in lymphoid organs","volume":"9","author":"Pellefigues","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.10.025_bib144","first-page":"358","article-title":"Detection of basophil sensitization by IgE antibodies to nuclear antigens in connective tissue diseases","volume":"69","author":"Camussi","year":"1982","journal-title":"Int Arch Allergy Appl Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib145","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1111\/cea.13984","article-title":"Mast cell activation tests by flow cytometry: a new diagnostic asset?","volume":"51","author":"Elst","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib146","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18176\/jiaci.0969","article-title":"LAD2 mast cell activation test associates with the reaction severity and diagnoses BAT nonresponders in Hymenoptera venom allergy","volume":"35","author":"Koren","year":"2025","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib147","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jaci.2021.07.027","article-title":"A novel approach for studying mast cell\u2013driven disorders: mast cells derived from induced pluripotent stem cells","volume":"149","author":"Luo","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib148","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.jaci.2021.08.006","article-title":"A novel functional mast cell assay for the detection of allergies","volume":"149","author":"Zbaren","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib149","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1126\/science.aau2599","article-title":"High-affinity allergen-specific human antibodies cloned from single IgE B cell transcriptomes","volume":"362","author":"Croote","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.jaci.2025.10.025_bib150","doi-asserted-by":"crossref","DOI":"10.3389\/falgy.2023.1270326","article-title":"Unique allergen-specific human IgE monoclonal antibodies derived from patients with allergic disease","volume":"4","author":"Smith","year":"2023","journal-title":"Front Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib151","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13601-019-0262-y","article-title":"Skin microdialysis: methods, applications and future opportunities\u2014an EAACI position paper","volume":"9","author":"Baumann","year":"2019","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib152","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/archinte.168.15.1657","article-title":"Prediction of progression to overt hypothyroidism or hyperthyroidism in female relatives of patients with autoimmune thyroid disease using the Thyroid Events Amsterdam (THEA) score","volume":"168","author":"Strieder","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib153","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1046\/j.1365-3083.2001.00959.x","article-title":"Development of anti-dsDNA autoantibodies prior to clinical diagnosis of systemic lupus erythematosus","volume":"54","author":"Arbuckle","year":"2001","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib154","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.44.4.245","article-title":"Detection of anti-dsDNA as a diagnostic tool: a prospective study in 441 non-systemic lupus erythematosus patients with anti-dsDNA antibody (anti-dsDNA)","volume":"44","author":"Swaak","year":"1985","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.jaci.2025.10.025_bib155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1523-1747.ep12329617","article-title":"Immunoglobulin E response to human proteins in atopic patients","volume":"107","author":"Valenta","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib156","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1272\/jnms.76.300","article-title":"Clinical features of antinuclear antibody-positive patients with atopic dermatitis","volume":"76","author":"Higashi","year":"2009","journal-title":"J Nippon Med Sch"},{"key":"10.1016\/j.jaci.2025.10.025_bib157","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12931-016-0441-5","article-title":"Perip7lakin is a target for autoimmunity in asthma","volume":"17","author":"Taill\u00e9","year":"2016","journal-title":"Respir Res"},{"key":"10.1016\/j.jaci.2025.10.025_bib158","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.jaci.2016.04.007","article-title":"Role of IgE in autoimmunity","volume":"137","author":"Sanjuan","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib159","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2024-004255","article-title":"Anti-dsDNA IgE: a potential non-invasive test for prediction of lupus nephritis relapse","volume":"10","author":"Himbert","year":"2024","journal-title":"RMD Open"},{"key":"10.1016\/j.jaci.2025.10.025_bib160","first-page":"1571","article-title":"Detection of IgE-autoantibodies to nuclear antigens in patients with systemic sclerosis and analysis of their clinical relevance","volume":"42","author":"Kramer","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib161","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00751-2020","article-title":"Omalizumab restores the ability of human plasmacytoid dendritic cells to induce Foxp3+ Tregs","volume":"57","author":"Lopez-Abente","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jaci.2025.10.025_bib162","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.3389\/fimmu.2019.01919","article-title":"Effects of omalizumab on FcepsilonRI and IgE expression in lesional skin of bullous pemphigoid","volume":"10","author":"Seyed Jafari","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib163","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0140-6736(23)01684-7","article-title":"Efficacy and safety of ligelizumab in adults and adolescents with chronic spontaneous urticaria: results of two phase 3 randomised controlled trials","volume":"403","author":"Maurer","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2025.10.025_bib164","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1111\/all.15567","article-title":"Ligelizumab impairs IgE-binding to plasmacytoid dendritic cells more potently than omalizumab and restores IFN-alpha production and FOXP3+ Treg generation","volume":"78","author":"Benito-Villalvilla","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib165","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1111\/all.16517","article-title":"The role of IgE in Crohn\u2019s disease by impairing the capacity of plasmacytoid dendritic cells to generate FOXP3+ Tregs","volume":"80","author":"de la Rocha-Munoz","year":"2025","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib166","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1111\/all.15449","article-title":"Regulatory T cells and immunoglobulin E: a new therapeutic link for autoimmunity?","volume":"77","author":"Palomares","year":"2022","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib167","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/bjd\/ljad369","article-title":"Omalizumab in the treatment of bullous pemphigoid resistant to first-line therapy: a French national multicentre retrospective study of 100 patients","volume":"190","author":"Chebani","year":"2024","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib168","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jaci.2011.04.038","article-title":"Efficacy and safety of omalizumab in patients with chronic urticaria who exhibit IgE against thyroperoxidase","volume":"128","author":"Maurer","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib169","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1002\/art.40828","article-title":"Safety and tolerability of omalizumab: a randomized clinical trial of humanized anti-IgE monoclonal antibody in systemic lupus erythematosus","volume":"71","author":"Hasni","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib170","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/ijd.13353","article-title":"Omalizumab for atopic dermatitis: case series and a systematic review of the literature","volume":"56","author":"Holm","year":"2017","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaci.2025.10.025_bib171","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/jamapediatrics.2019.4476","article-title":"Treatment effect of omalizumab on severe pediatric atopic dermatitis: the ADAPT randomized clinical trial","volume":"174","author":"Chan","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/j.jaci.2025.10.025_bib172","doi-asserted-by":"crossref","first-page":"378","DOI":"10.3390\/jcm12010378","article-title":"IgG and IgE autoantibodies to IgE receptors in chronic spontaneous urticaria and their role in the response to omalizumab","volume":"12","author":"Maronese","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib173","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1038\/s41467-021-22834-5","article-title":"Dual vaccination against IL-4 and IL-13 protects against chronic allergic asthma in mice","volume":"12","author":"Conde","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.10.025_bib174","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jaci.2018.08.022","article-title":"Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis","volume":"143","author":"Guttman-Yassky","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib175","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1111\/all.16108","article-title":"Targeting IL-13 with tralokinumab normalizes type 2 inflammation in atopic dermatitis both early and at 2 years","volume":"79","author":"Guttman-Yassky","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib176","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1056\/NEJMoa2408792","article-title":"Remibrutinib in chronic spontaneous urticaria","volume":"392","author":"Metz","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib177","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1038\/s41591-021-01537-w","article-title":"Fenebrutinib in H1 antihistamine\u2013refractory chronic spontaneous urticaria: a randomized phase 2 trial","volume":"27","author":"Metz","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib178","series-title":"Paper presented at: European Academy of Allergy and Clinical Immunology (EAACI) Congress","article-title":"Rilzabrutinib reduces IgG anti-thyroid peroxidase (anti-TPO), soluble Mas-related G protein-coupled receptor X2 (SMRGPRX2) and eosinophils at 12 weeks in patients with chronic spontaneous urticaria","author":"Maurer","year":"2024"},{"key":"10.1016\/j.jaci.2025.10.025_bib179","series-title":"Celldex presents unprecedented 76 week results from barzolvolimab phase 2 study in chronic spontaneous urticaria at EAACI Congress 2025","year":"2025"},{"key":"10.1016\/j.jaci.2025.10.025_bib180","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1002\/art.1780241120","article-title":"Systemic lupus erythematosus with only IgE-class antinuclear antibodies","volume":"24","author":"Barone","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.jaci.2025.10.025_bib181","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1365-2222.1990.tb02712.x","article-title":"Plasmapheresis in a patient with severe asthma associated with auto-antibodies to platelets","volume":"20","author":"Lassalle","year":"1990","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib182","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1023\/A:1020516029883","article-title":"The importance of specific IgG and IgE autoantibodies to retinal S antigen, total serum IgE, and sCD23 levels in autoimmune and infectious uveitis","volume":"19","author":"Muino","year":"1999","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib183","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/all.12711","article-title":"IgE responses to exogenous and endogenous allergens in atopic dermatitis patients under long-term systemic cyclosporine A treatment","volume":"71","author":"Lucae","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib185","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1365-2249.2008.03726.x","article-title":"Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells","volume":"153","author":"Fu","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2025.10.025_bib186","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/all.13119","article-title":"AllergoOncology\u2014the impact of allergy in oncology: EAACI position paper","volume":"72","author":"Jensen-Jarolim","year":"2017","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib187","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4161\/mabs.27029","article-title":"IgE immunotherapy: a novel concept with promise for the treatment of cancer","volume":"6","author":"Josephs","year":"2014","journal-title":"MAbs"},{"key":"10.1016\/j.jaci.2025.10.025_bib188","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00262-007-0371-7","article-title":"Role of IgE receptors in IgE antibody\u2013dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells","volume":"57","author":"Karagiannis","year":"2008","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jaci.2025.10.025_bib184","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib189","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115386","article-title":"Alteration of microbiota antibody-mediated immune selection contributes to dysbiosis in inflammatory bowel diseases","volume":"14","author":"Michaud","year":"2022","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jaci.2025.10.025_bib190","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/s41467-023-44373-x","article-title":"Gut microbiota facilitate chronic spontaneous urticaria","volume":"15","author":"Zhu","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jaci.2025.10.025_bib191","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2311-z","article-title":"Sialylation of immunoglobulin E is a determinant of allergic pathogenicity","volume":"582","author":"Shade","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jaci.2025.10.025_bib192","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1111\/all.16065","article-title":"Systematic review of the association between short-chain fatty acids and allergic diseases","volume":"79","author":"Sasaki","year":"2024","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2025.10.025_bib193","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2023.110739","article-title":"Short-chain fatty acid\u2014a critical interfering factor for allergic diseases","volume":"385","author":"Liu","year":"2023","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.jaci.2025.10.025_bib194","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/all.13567","article-title":"The soluble isoform of human FcvarepsilonRI is an endogenous inhibitor of IgE-mediated mast cell responses","volume":"74","author":"Monino-Romero","year":"2019","journal-title":"Allergy"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925011157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674925011157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:59:49Z","timestamp":1789174789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674925011157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":197,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0091674925011157"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.025","relation":{},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding IgE-mediated autoimmunity and autoallergy","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2025.10.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}